Ignite Creation Date:
2024-05-06 @ 10:41 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03324243
Status:
WITHDRAWN
Last Update Posted:
2019-01-10
First Post:
2017-10-18
Brief Title:
A Study of Crenolanib With Fludarabine and Cytarabine in Pediatric Patients With RelapsedRefractory FLT3-Mutated Acute Myeloid Leukemia
Sponsor:
Arog Pharmaceuticals Inc
Organization:
Arog Pharmaceuticals Inc
Organization Data
Organization:
Arog Pharmaceuticals Inc
Class:
INDUSTRY
Study ID:
ARO-014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Arog Pharmaceuticals Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None